Matthew Scott Harris - 23 Mar 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Chief Medical Officer
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
23 Mar 2023
Net transactions value
+$42,200
Form type
4
Filing time
23 Mar 2023, 20:28:29 UTC
Previous filing
06 Feb 2023
Next filing
02 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $42,200 +10,000 +43% $4.22 33,311 23 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.